Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial at University of Colorado, Denver is evaluating whether 5-ALA can improve surgical resection margins in soft tissue sarcoma; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-ALA (5-aminolevulinic acid)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Soft Tissue Sarcoma (STS) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING